Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2010 | 12-2009 | 12-2008 | 12-2006 | |
| Sales | 14,562 | 15,006 | 13,925 | 0 |
| Cost of Goods | 12,276 | 12,301 | 17,463 | N/A |
| Gross Profit | 2,286 | 2,705 | -3,538 | N/A |
| Operating Expenses | 25,271 | 31,554 | 42,288 | 0 |
| Operating Income | -22,709 | -28,548 | -45,363 | N/A |
| Interest Expense | 3,959 | 1,723 | 0 | 0 |
| Other Income | -481 | -1,436 | 3,501 | 0 |
| Pre-tax Income | -27,149 | -31,707 | -41,862 | 0 |
| Net Income Continuous | -27,149 | -31,707 | -41,862 | N/A |
| Net Income | $-27,149 | $-31,707 | $-41,862 | $N/A |
| EPS Basic Total Ops | -47.29 | -55.32 | -79.23 | N/A |
| EPS Basic Continuous Ops | -47.29 | -55.32 | -79.23 | N/A |
| EPS Diluted Total Ops | -47.29 | -55.32 | -79.23 | N/A |
| EPS Diluted Continuous Ops | -47.29 | -55.32 | -79.23 | N/A |
| EBITDA(a) | $-18,641 | $-24,116 | $-41,532 | $N/A |